Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-009587
Date:2020-09-03
Issuer: STRONGBRIDGE BIOPHARMA PLC (SBBP)
Original Submission Date:

Reporting Person:

GILL DAVID N
900 NORTHBROOK DRIVE
SUITE 200 TREVOSE, PA 19053

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2020-09-03 F 23,104 d $3.61 66,896 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 shares withheld by strongbridge biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.
WhaleWisdom Logo

Elevate your investments